-FY 2020 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government
-NDAA - provisions related to biological and chemical defense
-Department of Defense appropriations for Medical Countermeasures
-FDA regulatory issues
-Issues related to Priority Review Voucher programs
-Opioid and heroin addiction legislation, Naloxone access, coprescribing/opioid prescribing guidelines -FY 2020 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government
-Re-authorization of the Pandemic and All-Hazards Preparedness Act
-NDAA - provisions related to biological and chemical defense
-Department of Defense appropriations for Medical Countermeasures FDA regulatory issues
-Issues related to Priority Review Voucher programs
-Opioid and heroin addiction legislation, Naloxone access, coprescribing/opioid prescribing guidelines -FY 2020 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government
-NDAA - provisions related to biological and chemical defense
-Department of Defense appropriations for Medical Countermeasures
-FDA regulatory issues
-Issues related to Priority Review Voucher programs
-Opioid and heroin addiction legislation, Naloxone access, coprescribing/opioid prescribing guidelines
DIS - Disaster Planning/Emergencies BUD - Budget/Appropriations HOM - Homeland Security
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
EMERGENT BIOSOLUTIONS INC.
1455 Pennsylvania Avenue, NW, SUITE 1225, Washington, DC, 20004, US
CHRIS FRECH JILL HAMAKER GRANT BARBOSA KATHERINE GETTY GRANT BARBOSA KATHERINE GETTY CHRIS FRECH JILL HAMAKER GRANT BARBOSA KATHERINE GETTY